ArticleStem cells translational medicine2026
Low-intensity pulsed ultrasound regulates the osteogenic-adipogenic differentiation balance of rat adipose-derived stem cells via the PI3K/AKT-SREBF1 signaling axis.
Article in Stem cells translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rat adipose-derived stem cells (rADSCs) are widely used in bone tissue engineering (BTE). Low-intensity pulsed ultrasound (LIPUS) can modulate stem cell fate; however, its precise regulatory effects on ADSC lineage commitment remain unclear. This study aimed to elucidate how LIPUS regulates the osteogenic-adipogenic differentiation balance of rADSCs. We first performed cell proliferation and differentiation induction assays, which demonstrated that LIPUS significantly enhanced osteogenic differentiation while simultaneously suppressing adipogenesis, without affecting rADSC proliferation. Subsequently, transcriptome sequencing and protein-protein interaction analysis identified sterol regulatory element binding transcription factor 1 (Srebf1) as a pivotal regulatory node in LIPUS-modulated osteogenic-adipogenic differentiation. Rescue experiments further confirmed that LIPUS rescued the Srebf1 overexpression phenotype by restoring osteogenic potential and attenuating adipogenesis. Mechanistically, LIPUS downregulated SREBF1 expression and inhibited its nuclear translocation by inhibiting PI3K/AKT signaling, as evidenced by synergistic effects with the PI3K-specific inhibitor LY294002. Finally, a rat cranial defect model was established to validate the osteogenic potential of LIPUS in vivo. LIPUS significantly enhanced bone defect repair, even in the presence of Srebf1-overexpressing rADSCs. Collectively, our findings suggest that SREBF1, a canonical transcription factor in lipid metabolism, also functions as a mechanoresponsive regulator in cell fate determination. Furthermore, LIPUS promotes bone regeneration by shifting the osteogenic-adipogenic differentiation balance in rADSCs toward osteogenesis through suppression of PI3K/AKT-SREBF1 pathway, thereby providing a potential therapeutic strategy for BTE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.